Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1011 | 1011 | 1048 | 1286 | 1516 | 1938 |
Fund Return | 1.05% | 1.05% | 4.81% | 8.74% | 8.67% | 6.84% |
Place in category | 453 | 453 | 565 | 275 | 219 | 123 |
% in Category | 75 | 75 | 97 | 52 | 50 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Foord Balanced Fund C | 25.3B | 6.51 | 5.28 | 8.41 | ||
Foord Balanced Fund B4 | 24.31B | 11.26 | 9.53 | 6.98 | ||
Foord Balanced Fund B2 | 24.31B | 1.16 | 9.23 | 7.32 | ||
Foord Balanced Fund B1 | 24.31B | 1.12 | 9.04 | 7.14 | ||
Foord Balanced Fund B3 | 24.31B | 1.10 | 9.23 | 7.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allan Gray Balanced Fund A | 186.13B | 1.69 | 11.06 | 8.33 | ||
Allan Gray Balanced Fund C | 186.13B | -0.07 | 11.22 | 8.48 | ||
Allan Gray Balanced Fund X | 186.13B | 12.10 | 14.88 | - | ||
Coronation Balanced Plus Fund P | 111.88B | 3.10 | 9.48 | 8.42 | ||
Coronation Balanced Plus Fund D | 111.88B | 3.05 | 9.29 | 8.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Foord SICAV Foord International Fund B | LU0914416242 | 18.20 | 48.526 | +0.33% | |
Foord Global Equity Class X | SGXZ22939185 | 13.33 | - | - | |
Prosus | NL0013654783 | 6.33 | 33.25 | +1.71% | |
Foord Global Equity (Lux) X Cap | LU0914416838 | 5.80 | - | - | |
Aspen Pharmacare Holdings | ZAE000066692 | 4.71 | 22,772 | +0.46% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review